Please assess the completion status of the following clinical trial:

Trial Title: Side Effects of Bone Marrow Derived CD133 Transplantation in Cerebral Palsy

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. A diagnosis of spastic quadriplegic CP~2. Children must be between the ages of 4 and 12 years~3. Children must be cleared by an orthopedic surgeon for risk of hip subluxation or dislocation and cannot have significant scoliosis (curvature \> 40 degrees)~4. Children must be seizure-free or seizure controlled~Exclusion Criteria:~1. Children who have a diagnosis of mixed types of CP (i.e. athetosis) or other movement disorders (i.e. ataxia)~2. Children who have had a selective dorsal rhizotomy, are presently are receiving intrathecal Baclofen, or have changed their spasticity medications in the past 6 months.~3. Children who have a metallic or electrical implants

- Gender: ALL
- Minimum Age: 4 Years
- Maximum Age: 12 Years
- Healthy Volunteers: f

Study Arms:
- stem cell recipients (Type: EXPERIMENTAL): The 4-12 years old patients with cerebral palsy who undergone bone marrow derived CD133 transplantation

Based on this trial design, predict the completion outcome and termination type (if applicable).